Publikationen

  • 1. Wolf S, Lohbrunner H, Busch T, Deja M, Weber-Carstens S, Donaubauer B, et al. "Ideal PEEP" is superior to high dose partial liquid ventilation with low PEEP in experimental acute lung injury. Intensive Care Med 2001, Dec;27(12):1937-48.
  • 2. Deja M, Wolf S, Busch T, Petersen B, Jaghzies U, Boemke W, Kaisers U. The inhaled ET(A) receptor antagonist LU-135252 acts as a selective pulmonary vasodilator. Clin Sci (Lond) 2002, Aug;103 Suppl 48:21S-4S.
  • 3. Deja M, Busch T, Bachmann S, Riskowski K, Campean V, Wiedmann B, et al. Reduced nitric oxide in sinus epithelium of patients with radiologic maxillary sinusitis and sepsis. Am J Respir Crit Care Med 2003, Aug 1;168(3):281-6.
  • 4. Kaisers U, Busch T, Deja M, Donaubauer B, Falke KJ. Selective pulmonary vasodilation in acute respiratory distress syndrome. Crit Care Med 2003, Apr;31(4 Suppl):S337-42.
  • 7. Deja M, Busch T, Wolf S, Donaubauer B, Petersen B, Skomrock J, et al. Inhalation of the endothelin-a receptor antagonist LU-135252 at various doses in experimental acute lung injury. J Cardiovasc Pharmacol 2004, Nov;44 Suppl 1:S151-5.
  • 9. Wolf S, Höhne C, Busch T, Lohbrunner H, Weber-Carstens S, Kaisers U. [At which level is the PEEP adequate in ARDS?]. Anasthesiol Intensivmed Notfallmed Schmerzther 2005, Oct;40(10):597-601.
  • 10. Deja M, Hildebrandt B, Ahlers O, Riess H, Wust P, Gerlach H, Kerner T. Goal-directed therapy of cardiac preload in induced whole-body hyperthermia. Chest 2005, Aug;128(2):580-6.
  • 11. Hein OV, Misterek K, Tessmann JP, van Dossow V, Krimphove M, Spies C. Time course of endothelial damage in septic shock: Prediction of outcome. Crit Care 2005, Aug;9(4):R323-30.
  • 12. von Dossow V, Rotard K, Redlich U, Hein OV, Spies CD. Circulating immune parameters predicting the progression from hospital-acquired pneumonia to septic shock in surgical patients. Crit Care 2005;9(6):R662-9.
  • 13. Bercker S, Weber-Carstens S, Deja M, Grimm C, Wolf S, Behse F, et al. Critical illness polyneuropathy and myopathy in patients with acute respiratory distress syndrome. Crit Care Med 2005, Apr;33(4):711-5.
  • 14. Ahlers O, Hildebrandt B, Dieing A, Deja M, Böhnke T, Wust P, et al. Stress induced changes in lymphocyte subpopulations and associated cytokines during whole body hyperthermia of 41.8-42.2 degrees C. Eur J Appl Physiol 2005, Oct;95(4):298-306.
  • 15. Röttgen R, Busch T, Lohbrunner H, Einfeld H, Deja M, Schroeder RJ, et al. [Computed tomographic criteria as expected effect to inhaled nitric oxide in patients with severe acute respiratory distress syndrome]. Rofo 2005, Jun;177(6):805-11.
  • 16. Nachtigall I, Deja M, Halle E, Kastrup M, Weber-Carstens S, Krieg H, et al. [Implementation of standard operating procedures for the initial empirical antimicrobial therapy for adults--a new computer program at the university hospital charité]. Anasthesiol Intensivmed Notfallmed Schmerzther 2006, Oct;41(10):626-35.
  • 17. Deja M, Denke C, Weber-Carstens S, Schröder J, Pille CE, Hokema F, et al. Social support during intensive care unit stay might improve mental impairment and consequently health-related quality of life in survivors of severe acute respiratory distress syndrome. Crit Care 2006;10(5):R147.
  • 18. Donaubauer B, Busch T, Lachmann R, Deja M, Petersen B, Francis R, et al. Low-dose inhalation of an endothelin-a receptor antagonist in experimental acute lung injury: ET-1 plasma concentration and pulmonary inflammation. Exp Biol Med (Maywood) 2006, Jun;231(6):960-6.
  • 19. Busch T, Petersen B, Deja M, Donaubauer B, Laudi S, Jaumann S, et al. Endothelin-1 influences the efficacy of inhaled nitric oxide in experimental acute lung injury. Exp Biol Med (Maywood) 2006, Jun;231(6):974-8.
  • 20. Deja M, Wolf S, Weber-Carstens S, Lehmann TN, Adler A, Ruhnke M, Tintelnot K. Gastrointestinal zygomycosis caused by mucor indicus in a patient with acute traumatic brain injury. Med Mycol 2006, Nov;44(7):683-7.
  • 21. Spies CD, Nachtigall I, Kastrup M, Deja M. [Standards, guidelines and recommendations for antibiotic therapy]. Anasthesiol Intensivmed Notfallmed Schmerzther 2007, Feb;42(2):106-7.
  • 22. Deja M. [An appendix on the strategies for the prescription of antibiotics in intensive care: Standards for microbiological diagnostics]. Anasthesiol Intensivmed Notfallmed Schmerzther 2007, Feb;42(2):108-10.
  • 23. Deja M, Nachtigall I, Halle E, Kastrup M, Guill MM, Spies CD. [Strategies in the treatment of infections with antibiotics in intensive care medicine]. Anasthesiol Intensivmed Notfallmed Schmerzther 2007, Feb;42(2):108-15.
  • 24. Gericke B, Raila J, Deja M, Rohn S, Donaubauer B, Nagl B, et al. Alteration of transthyretin microheterogeneity in serum of multiple trauma patients. Biomark Insights 2007;2:299-306.
  • 25. Weber-Carstens S, Keh D. Bolus or continuous hydrocortisone--that is the question. Crit Care 2007;11(1):113.
  • 27. Weber-Carstens S, Deja M, Bercker S, Dimroth A, Ahlers O, Kaisers U, Keh D. Impact of bolus application of low-dose hydrocortisone on glycemic control in septic shock patients. Intensive Care Med 2007, Apr;33(4):730-3.
  • 28. Heymann A, Sander M, Krahne D, Deja M, Weber-Carstens S, MacGuill M, et al. Hyperactive delirium and blood glucose control in critically ill patients. J Int Med Res 2007;35(5):666-77.
  • 29. Spies CD, Lanzke N, Schlichting U, Muehlbauer S, Pipolo C, von Mettenheim M, et al. Effects of ethanol on cytokine production after surgery in a murine model of gram-negative pneumonia. Alcohol Clin Exp Res 2008, Feb;32(2):331-8.
  • 30. Petersen B, Deja M, Bartholdy R, Donaubauer B, Laudi S, Francis RC, et al. Inhalation of the ETA receptor antagonist LU-135252 selectively attenuates hypoxic pulmonary vasoconstriction. Am J Physiol Regul Integr Comp Physiol 2008, Feb;294(2):R601-5.
  • 31. Deja M, Hommel M, Goldmann A, Pille C, von Dossow V, Lojewski C, Spies C. [Lung diseases--multimodal adult respiratory distress syndrome(ARDS)--therapy requires evidence-based studies with clear criteria of results]. Anasthesiol Intensivmed Notfallmed Schmerzther 2008, Nov;43(11-12):756-7.
  • 32. Deja M, Lojewski C, Hommel M, Menk M, Weimann J. [Epidemiology and pathophysiology of the acute respiratory distress syndrome (ARDS)]. Anasthesiol Intensivmed Notfallmed Schmerzther 2008, Nov;43(11-12):758-66; quiz 768.
  • 33. Bein T, Weber-Carstens S. [Techniques of extracorporeal lung support]. Anasthesiol Intensivmed Notfallmed Schmerzther 2008, Nov;43(11-12):786-91; quiz 793.
  • 34. Kalk P, Senf P, Deja M, Petersen B, Busch T, Bauer C, et al. Inhalation of an endothelin receptor A antagonist attenuates pulmonary inflammation in experimental acute lung injury. Can J Physiol Pharmacol 2008, Aug;86(8):511-5.
  • 35. Keh D, Weber-Carstens S, Ahlers O. Adjunctive therapies in severe sepsis and septic shock: Current place of steroids. Curr Infect Dis Rep 2008, Sep;10(5):354-61.
  • 36. Hommel M, Deja M, von Dossow V, Diemel K, Heidenhain C, Spies C, Weber-Carstens S. Bronchial fistulae in ARDS patients: Management with an extracorporeal lung assist device. Eur Respir J 2008, Dec;32(6):1652-5.
  • 37. Deja M, Hommel M, Weber-Carstens S, Moss M, von Dossow V, Sander M, et al. Evidence-based therapy of severe acute respiratory distress syndrome: An algorithm-guided approach. J Int Med Res 2008;36(2):211-21.
  • 38. Bein T, Müller T, Weber-Carstens S. [Extracorporeal lung support procedures (ECMO/ila)]. Pneumologie 2008, Mar;62(3):137-42.
  • 39. Meisel C, Schefold JC, Pschowski R, Baumann T, Hetzger K, Gregor J, et al. Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: A double-blind, randomized, placebo-controlled multicenter trial. Am J Respir Crit Care Med 2009, Oct 1;180(7):640-8.
  • 40. Nachtigall I, Tamarkin A, Tafelski S, Deja M, Halle E, Gastmeier P, et al. Impact of adherence to standard operating procedures for pneumonia on outcome of intensive care unit patients. Crit Care Med 2009, Jan;37(1):159-66.
  • 42. Koulenti D, Lisboa T, Brun-Buisson C, Krueger W, Macor A, Sole-Violan J, et al. Spectrum of practice in the diagnosis of nosocomial pneumonia in patients requiring mechanical ventilation in european intensive care units. Crit Care Med 2009, Aug;37(8):2360-8.
  • 43. Weber-Carstens S, Koch S, Spuler S, Spies CD, Bubser F, Wernecke KD, Deja M. Nonexcitable muscle membrane predicts intensive care unit-acquired paresis in mechanically ventilated, sedated patients. Crit Care Med 2009, Sep;37(9):2632-7.
  • 44. Kenn S, Weber-Carstens S, Weizsaecker K, Bercker S. Prone positioning for ARDS following blunt chest trauma in late pregnancy. Int J Obstet Anesth 2009, Jul;18(3):268-71.
  • 45. Francis RC, Schefold JC, Bercker S, Temmesfeld-Wollbrück B, Weichert W, Spies CD, Weber-Carstens S. Acute respiratory failure after aspiration of activated charcoal with recurrent deposition and release from an intrapulmonary cavern. Intensive Care Med 2009, Feb;35(2):360-3.
  • 46. Weber-Carstens S, Bercker S, Hommel M, Deja M, MacGuill M, Dreykluft C, Kaisers U. Hypercapnia in late-phase ALI/ARDS: Providing spontaneous breathing using pumpless extracorporeal lung assist. Intensive Care Med 2009, Jun;35(6):1100-5.
  • 47. Weber-Carstens S, Deja M, Koch S, Spranger J, Bubser F, Wernecke KD, et al. Risk factors in critical illness myopathy during the early course of critical illness: A prospective observational study. Crit Care 2010;14(3):R119.
  • 48. Winkelman C. The role of inflammation in icu-acquired weakness. Crit Care 2010;14(4):186.
  • 49. Deja M, Ahlers O, Macguill M, Wust P, Hildebrandt B, Riess H, Kerner T. Changes in hepatic blood flow during whole body hyperthermia. Int J Hyperthermia 2010;26(2):95-100.
  • 50. Schefold JC, Bierbrauer J, Weber-Carstens S. Intensive care unit-acquired weakness (ICUAW) and muscle wasting in critically ill patients with severe sepsis and septic shock. J Cachexia Sarcopenia Muscle 2010, Dec;1(2):147-57.
  • 51. Magret M, Amaya-Villar R, Garnacho J, Lisboa T, Díaz E, Dewaele J, et al. Ventilator-associated pneumonia in trauma patients is associated with lower mortality: Results from EU-VAP study. J Trauma 2010, Oct;69(4):849-54.
  • 53. Windisch W, Walterspacher S, Siemon K, Geiseler J, Sitter H, German Society for Pneumology. Guidelines for non-invasive and invasive mechanical ventilation for treatment of chronic respiratory failure. Published by the german society for pneumology (DGP). Pneumologie 2010, Oct;64(10):640-52.
  • 54. Nin N, Lombardi R, Frutos-Vivar F, Esteban A, Lorente JA, Ferguson ND, et al. Early and small changes in serum creatinine concentrations are associated with mortality in mechanically ventilated patients. Shock 2010, Aug;34(2):109-16.
  • 55. Blot SI, Serra ML, Koulenti D, Lisboa T, Deja M, Myrianthefs P, et al. Patient to nurse ratio and risk of ventilator-associated pneumonia in critically ill patients. Am J Crit Care 2011, Jan;20(1):e1-9.
  • 56. Peñuelas O, Frutos-Vivar F, Fernández C, Anzueto A, Epstein SK, Apezteguía C, et al. Characteristics and outcomes of ventilated patients according to time to liberation from mechanical ventilation. Am J Respir Crit Care Med 2011, Aug 15;184(4):430-7.
  • 57. Krebs M, Weber-Carstens S. [Acquired neuromuscular weakness : Underestimated problem in intensive care medicine]. Anaesthesist 2011, Oct;60(10):885-6.
  • 58. Weber-Carstens S, Bierbrauer J, Spies CD. [Insulin resistance: Importance in anesthesia and intensive care - the conflict between hyperglycemia, hyperinsulinemia and malnutrition]. Anasthesiol Intensivmed Notfallmed Schmerzther 2011, Apr;46(4):248-9.
  • 59. Bierbrauer J, Weber-Carstens S. [Insulin resistance and protein catabolism in critically ill patients]. Anasthesiol Intensivmed Notfallmed Schmerzther 2011, Apr;46(4):268-74; quiz 275.
  • 60. Deja M, Trefzer T, Geffers C. [Prevention of ventilator-associated pneumonia: What's evidence-based treatment?]. Anasthesiol Intensivmed Notfallmed Schmerzther 2011, Sep;46(9):560-7.
  • 61. Russ M, Deja M, Ott S, Bedarf J, Keckel T, Hiebl B, et al. Experimental high-volume hemofiltration with predilutional tris-hydroxymethylaminomethane for correction of low tidal volume ventilation-induced acidosis. Artif Organs 2011, Jun;35(6):E108-18.
  • 62. Bein T, Zimmermann M, Philipp A, Ramming M, Sinner B, Schmid C, et al. Addition of acetylsalicylic acid to heparin for anticoagulation management during pumpless extracorporeal lung assist. ASAIO J 2011;57(3):164-8.
  • 63. Lombardi R, Nin N, Lorente JA, Frutos-Vivar F, Ferguson ND, Hurtado J, et al. An assessment of the acute kidney injury network creatinine-based criteria in patients submitted to mechanical ventilation. Clin J Am Soc Nephrol 2011, Jul;6(7):1547-55.
  • 65. Pelosi P, Ferguson ND, Frutos-Vivar F, Anzueto A, Putensen C, Raymondos K, et al. Management and outcome of mechanically ventilated neurologic patients. Crit Care Med 2011, Jun;39(6):1482-92.
  • 67. Valentin A, Ferdinande P, ESICM Working Group on Quality Improvement. Recommendations on basic requirements for intensive care units: Structural and organizational aspects. Intensive Care Med 2011, Oct;37(10):1575-87.
  • 68. Koch S, Spuler S, Deja M, Bierbrauer J, Dimroth A, Behse F, et al. Critical illness myopathy is frequent: Accompanying neuropathy protracts ICU discharge. J Neurol Neurosurg Psychiatry 2011, Mar;82(3):287-93.
  • 69. Deja M, Menk M, Heidenhain C, Spies CD, Heymann A, Weidemann H, et al. Strategies for diagnosis and treatment of iatrogenic tracheal ruptures. Minerva Anestesiol 2011, Dec;77(12):1155-66.
  • 70. Weber-Carstens S, Francis RC, Spies CD. [Increased intracranial pressure - an interdisciplinary challenge in the operating room and intensive care]. Anasthesiol Intensivmed Notfallmed Schmerzther 2012, Jan;47(1):28-9.
  • 71. Rosenthal C, Wolf S, Weber-Carstens S, Salih F. [Intracranial hypertension - therapeutic options]. Anasthesiol Intensivmed Notfallmed Schmerzther 2012, Jan;47(1):30-8; quiz 39.
  • 72. Töpfer L, Weber-Carstens S, von Dossow-Hanfstingl V. [Which kind of therapy for which patient? Choosing the ventilator strategy in ARDS]. Anasthesiol Intensivmed Notfallmed Schmerzther 2012, Oct;47(10):626-35.
  • 73. Bierbrauer J, Koch S, Olbricht C, Hamati J, Lodka D, Schneider J, et al. Early type II fiber atrophy in intensive care unit patients with nonexcitable muscle membrane. Crit Care Med 2012, Feb;40(2):647-50.
  • 74. Luetz A, Goldmann A, Weber-Carstens S, Spies C. Weaning from mechanical ventilation and sedation. Curr Opin Anaesthesiol 2012, Apr;25(2):164-9.
  • 75. Grieser C, Goldmann A, Steffen IG, Kastrup M, Fernández CM, Engert U, et al. Computed tomography findings from patients with ARDS due to influenza A (H1N1) virus-associated pneumonia. Eur J Radiol 2012, Feb;81(2):389-94.
  • 76. Dreier JP, Drenckhahn C, Woitzik J, Major S, Offenhauser N, Weber-Carstens S, et al. Spreading ischemia after aneurysmal subarachnoid hemorrhage. Acta Neurochir Suppl 2013;115:125-9.
  • 77. Weber-Carstens S, Schneider J, Wollersheim T, Assmann A, Bierbrauer J, Marg A, et al. Critical illness myopathy and GLUT4: Significance of insulin and muscle contraction. Am J Respir Crit Care Med 2013, Feb 15;187(4):387-96.
  • 79. Pickerodt PA, Francis RC, Weber-Carstens S. [Monitoring of the respiratory muscle function during weaning from mechanical ventilation]. Anasthesiol Intensivmed Notfallmed Schmerzther 2013, Oct;48(10):634-9.
  • 80. Weber-Carstens S, Goldmann A, Quintel M, Kalenka A, Kluge S, Peters J, et al. Extracorporeal lung support in H1N1 provoked acute respiratory failure: The experience of the german ARDS network. Dtsch Arztebl Int 2013, Aug;110(33-34):543-9.
  • 81. Dalhoff K, Ewig S, Abele-Horn M, Andreas S, Bauer TT, von Baum H, et al. Adult patients with nosocomial pneumonia: Epidemiology, diagnosis, and treatment. Dtsch Arztebl Int 2013, Sep;110(38):634-40.
  • 82. Braun JP, Kumpf O, Deja M, Brinkmann A, Marx G, Bloos F, et al. The german quality indicators in intensive care medicine 2013--second edition. Ger Med Sci 2013;11:Doc09.
  • 83. Kipping V, Weber-Carstens S, Lojewski C, Feldmann P, Rydlewski A, Boemke W, et al. Prone position during ECMO is safe and improves oxygenation. Int J Artif Organs 2013, Nov;36(11):821-32.
  • 84. Meyer E, Gastmeier P, Deja M, Schwab F. Antibiotic consumption and resistance: Data from europe and germany. Int J Med Microbiol 2013, Aug;303(6-7):388-95.
  • 85. Martin-Loeches I, Deja M, Koulenti D, Dimopoulos G, Marsh B, Torres A, et al. Potentially resistant microorganisms in intubated patients with hospital-acquired pneumonia: The interaction of ecology, shock and risk factors. Intensive Care Med 2013, Apr;39(4):672-81.
  • 86. Bein T, Weber-Carstens S, Goldmann A, Müller T, Staudinger T, Brederlau J, et al. Lower tidal volume strategy (≈3 ml/kg) combined with extracorporeal CO2 removal versus 'conventional' protective ventilation (6 ml/kg) in severe ARDS: The prospective randomized xtravent-study. Intensive Care Med 2013, May;39(5):847-56.
  • 87. Ohlraun S, Wollersheim T, Weiß C, Martus P, Weber-Carstens S, Schmitz D, Schuelke M. CARbon dioxide for the treatment of febrile seizures: Rationale, feasibility, and design of the cardif-study. J Transl Med 2013;11:157.
  • 88. Rello J, Molano D, Villabon M, Reina R, Rita-Quispe R, Previgliano I, et al. Differences in hospital- and ventilator-associated pneumonia due to staphylococcus aureus (methicillin-susceptible and methicillin-resistant) between europe and latin america: A comparison of the EUVAP and LATINVAP study cohorts. Med Intensiva 2013, May;37(4):241-7.
  • 89. Woitzik J, Hecht N, Pinczolits A, Sandow N, Major S, Winkler MK, et al. Propagation of cortical spreading depolarization in the human cortex after malignant stroke. Neurology 2013, Mar 19;80(12):1095-102.
  • 90. Schmidt F, Kny M, Zhu X, Wollersheim T, Persicke K, Langhans C, et al. The E3 ubiquitin ligase TRIM62 and inflammation-induced skeletal muscle atrophy. Crit Care 2014;18(5):545.
  • 91. Blot S, Koulenti D, Dimopoulos G, Martin C, Komnos A, Krueger WA, et al. Prevalence, risk factors, and mortality for ventilator-associated pneumonia in middle-aged, old, and very old critically ill patients*. Crit Care Med 2014, Mar;42(3):601-9.
  • 92. Kumpf O, Bloos F, Bause H, Brinkmann A, Deja M, Marx G, et al. Voluntary peer review as innovative tool for quality improvement in the intensive care unit--a retrospective descriptive cohort study in german intensive care units. Ger Med Sci 2014;12:Doc17.
  • 93. Wollersheim T, Woehlecke J, Krebs M, Hamati J, Lodka D, Luther-Schroeder A, et al. Dynamics of myosin degradation in intensive care unit-acquired weakness during severe critical illness. Intensive Care Med 2014, Apr;40(4):528-38.
  • 94. Töpfer L, Menk M, Weber-Carstens S, Spies C, Wernecke KD, Uhrig A, et al. Influenza A (H1N1) vs non-h1n1 ARDS: Analysis of clinical course. J Crit Care 2014, Jun;29(3):340-6.
  • 95. Nachtigall I, Tamarkin A, Tafelski S, Weimann A, Rothbart A, Heim S, et al. Polymorphisms of the toll-like receptor 2 and 4 genes are associated with faster progression and a more severe course of sepsis in critically ill patients. J Int Med Res 2014, Feb;42(1):93-110.
  • 96. Weber-Carstens S. [Acute muscle loss in critically ill patients]. Med Klin Intensivmed Notfmed 2014, May;109(4):276-7.
  • 97. Koch S, Wollersheim T, Bierbrauer J, Haas K, Mörgeli R, Deja M, et al. Long-term recovery in critical illness myopathy is complete, contrary to polyneuropathy. Muscle Nerve 2014, Sep;50(3):431-6.
  • 98. Langhans C, Weber-Carstens S, Schmidt F, Hamati J, Kny M, Zhu X, et al. Inflammation-induced acute phase response in skeletal muscle and critical illness myopathy. PLoS One 2014;9(3):e92048.
  • 99. Schönhofer B, Geiseler J, Dellweg D, Moerer O, Barchfeld T, Fuchs H, et al. [Prolonged weaning: S2k-guideline published by the german respiratory society]. Pneumologie 2014, Jan;68(1):19-75.
  • 100. Bein T, Weber-Carstens S, Herridge M. Extracorporeal life support, ethics, and questions at the bedside: How does the end of the pathway look? Intensive Care Med 2015, Feb 25.
  • 101. Tafelski S, Nachtigall I, Troeger U, Deja M, Krannich A, Günzel K, et al. Observational clinical study on the effects of different dosing regimens on vancomycin target levels in critically ill patients: Continuous versus intermittent application. J Infect Public Health 2015, Mar 17.
  • 102. Tafelski S, Nachtigall I, Adam T, Bereswill S, Faust J, Tamarkin A, et al. Randomized controlled clinical trial evaluating multiplex polymerase chain reaction for pathogen identification and therapy adaptation in critical care patients with pulmonary or abdominal sepsis. J Int Med Res 2015, Jun;43(3):364-77.
  • 103. Bein T, Müller T, Graf BM, Philipp A, Zeman F, Schultz MJ, et al. Factors of tidal volume variation during augmented spontaneous ventilation in patients on extracorporeal carbon dioxide removal. A multivariate analysis. Minerva Anestesiol 2015, Jan;81(1):28-32.